Which health-related quality of life aspects are important to patients with chronic myeloid leukemia receiving targeted therapies and to health care professionals?

Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population

(2011) F. Efficace et al.   BLOOD

Time for a new era in the evaluation of targeted therapies for patients with chronic myeloid leukemia: Inclusion of quality of life and other patient-reported outcomes

(2011) F. Efficace et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Use of Patient-Reported Outcomes to Improve the Predictive Accuracy of Clinician-Reported Adverse Events

(2011) E. Basch et al.   JNCI-Journal of the National Cancer Institute

Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib

(2011) Carlo Gambacorti-Passerini et al.   JNCI-Journal of the National Cancer Institute

Educational Session: Managing Chronic Myeloid Leukemia as a Chronic Disease

(2011) A. Hochhaus   Hematology-American Society of Hematology Education Program

Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results

(2010) H. M. Kantarjian et al.   BLOOD

Intolerance to tyrosine kinase inhibitors in chronic myeloid leukemia

(2010) Javier Pinilla-Ibarz et al.   CANCER

Health care providers underestimate symptom intensities of cancer patients: A multicenter European study

(2010) Eivor A. Laugsand et al.   Health and Quality of Life Outcomes

Clinical Cancer Advances 2010: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

(2010) Mark G. Kris et al.   JOURNAL OF CLINICAL ONCOLOGY

Adherence Is the Critical Factor for Achieving Molecular Responses in Patients With Chronic Myeloid Leukemia Who Achieve Complete Cytogenetic Responses on Imatinib

(2010) David Marin et al.   JOURNAL OF CLINICAL ONCOLOGY

Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia

(2010) Giuseppe Saglio et al.   NEW ENGLAND JOURNAL OF MEDICINE

Patients’ and health care professionals’ evaluation of health-related quality of life issues in bone metastases

(2009) Kristin Harris et al.   EUROPEAN JOURNAL OF CANCER

Results of Dasatinib Therapy in Patients With Early Chronic-Phase Chronic Myeloid Leukemia

(2009) Jorge E. Cortes et al.   JOURNAL OF CLINICAL ONCOLOGY